CHINA AOYUAN (03883) issues 635,000 shares upon conversion of convertible bonds.
CHINA AOYUAN (03883) announced that on September 21, 2026, 635,000 shares were issued upon conversion of convertible bonds.
CHINA AOYUAN (03883) announced that on September 21, 2026, 635,000 shares were issued upon conversion of convertible bonds.
Related Articles
Hefei Lifeon Pharmaceutical (003020.SZ): Marketing application for dexmethylphenidate hydrochloride API approved
ZhuZhou QianJin Pharmaceutical (600479.SH): Ferrous Succinate Tablets and Escitalopram Oxalate Tablets Obtain Drug Registration Certificates
Kexing Biopharm (688136.SH): GB20 Injection Receives Drug Clinical Trial Approval Notice
Hefei Lifeon Pharmaceutical (003020.SZ): Marketing application for dexmethylphenidate hydrochloride API approved
ZhuZhou QianJin Pharmaceutical (600479.SH): Ferrous Succinate Tablets and Escitalopram Oxalate Tablets Obtain Drug Registration Certificates
Kexing Biopharm (688136.SH): GB20 Injection Receives Drug Clinical Trial Approval Notice
RECOMMEND
